3. Walter MJ, Holtzman MJ. A centennial history of research on asthma pathogenesis. Am J Respir Cell Mol Biol, 2005, 32(6): 483-489.
[4]
4. Holgate ST. Pathogenesis of asthma. Clin Exp Allergy, 2008, 38(6): 872-897.
[5]
5. Kumar V, Pandey A, Jahan S, et al. Differential responses of Trans-Resveratrol on proliferation of neural progenitor cells and aged rat hippocampal neurogenesis. Sci Rep, 2016, 6: 28142.
[6]
6. Lee M, Kim S, Kwon OK, et al. Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Int Immunopharmacol, 2009, 9(4): 418-424.
[7]
7. Aich J, Mabalirajan U, Ahmad T, et al. Resveratrol attenuates experimental allergic asthma in mice by restoring inositol polyphosphate 4 phosphatase (INPP4A). Int Immunopharmacol, 2012, 14(4): 438-443.
[8]
8. Ni ZH, Tang JH, Chen G, et al. Resveratrol inhibits mucus overproduction and MUC5AC expression in a murine model of asthma. Mol Med Rep, 2016, 13(1): 287-294.
[9]
9. Wei G, Chen X, Wang G, et al. Effect of resveratrol on the prevention of intra-abdominal adhesion formation in a rat model. Cell Physiol Biochem, 2016, 39(1): 33-46.
[10]
10. Chang YC, Lin CW, Yu CC, et al. Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the ep IgE netic inhibition of ZEB1 expression. Oncotarget, 2016, 7(11): 12137-12149.
[11]
11. Raj P, Aloud BM, Louis XL, et al. Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats. J Nutr Biochem, 2016, 28: 155-163.
[12]
12. Ma Y, Ge A, Zhu W, et al. Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling. Oxid Med Cell Longev, 2016: 5843672. Available at: https://www.hindawi.com/journals/omcl/2016/5843672/.
[13]
13. Royce SG, Shen M, Patel KP, et al. Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease. Stem Cell Res, 2015,15(3): 495-505.
15. Zhu T, Zhang W, Wang DX, et al. Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type A receptor. Chin Med J (Engl), 2012, 125(8): 1457-1464.
[16]
16. Ren Y, Su XM, Kong LF, et al. Therapeutic effects of histone deacetylase inhibitors in a murine asthma model. Inflamm Res, 2016,65(12): 995-1008.
[17]
17. Collison A, Li J, Pereira De Siqueira A, et al. Tumor necrosis factor-related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease. Am J Respir Cell and Mol Biol, 2014,51(1): 86-93.
[18]
18. Difazio RM, Mattila JT, Klein EC, et al. Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis. Fibrogenesis Tissue Repair, 2016, 9: 6.
[19]
19. Mamalis A, Jagdeo J. The combination of resveratrol and high-fluence light emitting diode-red light produces synergistic photobotanical inhibition of fibroblast proliferation and collagen synthesis: a novel treatment for skin fibrosis. Dermatol Surg, 2017, 43(1): 81-86.
[20]
20. Fagone E, Conte E, Gili, E, et al. Resveratrol inhibits transforming growth factor-β-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration. Exp Lung Res, 2011,3(37): 162-174.
[21]
21. Shi Y, Xu X, Tan Y, et al. A liver-X-receptor ligand, T0901317, attenuates IgE production and airway remodeling in chronic asthma model of mice. PLos One, 2014, 3(9): e92668.
[22]
22. Gao YD, Zou JJ, Zheng JW, et al. Promoting effects of IL-13 on Ca2+ release and store-operated Ca2+ entry in airway smooth muscle cells. Pulm Pharmacol Ther, 2010, 23(3): 182-189.
24. Cheung TM, Ganatra MP,Truskey GA, et al. Effect of cellular senescence on the albumin permeability of blood-derived endothelial cells. Am J Physiol Heart Circ Physiol, 2012, 303(11): H1374-H1383.
[25]
25. Chen JX, Zhou H, Wang JL, et al. Therapeutic effects of resveratrol in a mouse model of HDM-induced allergic asthma. Int Immunopharmacol, 2015, 25(1): 43-48.
